Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trade Secrets Case Watch
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Health Care

Insights on Health Care

1213 total results. Page 1 of 49.

Investigations Blog
Zafirov One Year Later: Constitutional Challenges to the False Claims Act’s Qui Tam Provision
December 4, 2025
Nadia Patel, John M. Hindley

Judge Kathryn Kimball Mizelle’s ground-breaking decision in Zafirov v. Florida Medical Associates LLC and Justice Clarence Thomas’ solo dissent in US ex rel. Polansky v. Executive Health Resources Inc. have revived what many had viewed as a settled constitutional question.

Alerts
Whoop There It Is: FDA Warning Letter Now Anchors a Class Action Against Whoop
December 3, 2025
Abha Kundi*, Gayland O. Hethcoat II

A putative class action against Whoop, the wearable technology company, uses the US Food and Drug Administration’s (FDA) July 2025 warning letter regarding its new blood pressure product feature as a litigation springboard. The case shows how misalignment with regulators’ expectations can quickly cascade from agency scrutiny to consumer litigation.

Alerts
CMS Issues 2026 Hospital Outpatient Prospective Payment System Final Rule: Key Takeaways for Pharma
December 1, 2025
Stephanie Trunk, Shoshana Golden

On November 21, the Centers for Medicare & Medicaid Services (CMS) issued a final rule announcing changes for Medicare payments for hospital outpatient services under the Hospital Outpatient Prospective Payment System (HOPPS).

Alerts
Class Action Challenges ERISA Compliance of Tobacco Cessation Program
November 26, 2025
Alison Lima Andersen, Mattie Bowden

Generally, the Employee Retirement Income Security Act of 1974 (ERISA) prohibits discrimination based on a plan participant’s health status-related factor, such as a medical condition, medical history, or genetic information.

Alerts
Update on CMS 2026 Physician Fee Schedule Final Rule: Key Takeaways for Pharma
November 25, 2025
Stephanie Trunk, Shoshana Golden

After issuing the Physician Fee Schedule (PFS) on October 31, the Centers for Medicare & Medicaid Services (CMS) has now published templates for manufacturers to utilize when complying with new requirements regarding the submission of reasonable assumptions related to their average sales price (ASP) calculations. CMS also mandates that manufacturers submit Bona Fide Service Fee (BFSF) certification or warranty letters for new or renewal contracts dated January 1, 2026, or later that contain BFSFs with quarterly ASP.

Investigations Blog
Medtronic FCA Claims Survive Reconsideration Despite First Circuit’s But-For Causation Standard
November 24, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Pascal Naples, James G. Pizzo

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Jury Finds Global Health Care Company Novo Nordisk Not Liable in Whistleblower’s FCA Suit
November 17, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, James G. Pizzo

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
CMS Issues 2026 Physician Fee Schedule Final Rule: Key Takeaways for Pharma
November 12, 2025
Stephanie Trunk, Shoshana Golden

On October 31, the Centers for Medicare & Medicaid Services (CMS) issued a final rule announcing changes for Medicare payments under the Physician Fee Schedule (PFS), effective on or after January 1, 2026.

News
Grimm Quoted on Hospital Challenges and Joint Operating Agreements
November 11, 2025
Douglas A. Grimm

Health Care Practice Leader Douglas Grimm was quoted in a recent article discussing the rising popularity of joint operating agreements (JOAs) among health systems facing industry pressures.

Alerts
Top Four FDA Compliance Issues for Hospitals and Health Systems: What They Are, Why They Matter, and What To Watch
November 11, 2025
Abha Kundi*

The US Food and Drug Administration (FDA) regulates the products hospitals and health systems use, make, or study. As health system innovations increasingly leap quickly across service lines, regulatory obligations can shift in real time.

Investigations Blog
Fifth Circuit Judge Questions Constitutionality of the FCA’s Qui Tam Provision
November 10, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Meghan F. Hart, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
Six Good Things Congress Should Do Before December 31
November 6, 2025
Cissy Jackson, Audrey Hazel*, Katherine Kramer*, Starshine S. Chun*, Jon S. Bouker, Dan H. Renberg

In the midst of a record-setting government shutdown, partisan divisions are deep, and legislating can appear zero-sum.

Press Release
ArentFox Schiff Earns 62 Top ‘Best Law Firms’ Rankings
November 6, 2025

ArentFox Schiff has been awarded 62 top rankings in the 2026 edition of Best Law Firms®, which recognizes firms for professional excellence based on consistently positive ratings from clients and peers.

Alerts
Safe Chain Shows the DSCSA Is a Compliance Mandate and a Criminal Boundary
November 4, 2025
Abha Kundi*

Last week’s jury convictions of Safe Chain Solutions’ co-owners in United States v. Brosius, No. 1:24-cr-20255 (S.D. Fla.) coupled with US Food and Drug Administration (FDA) Drug Supply Chain Security Act (DSCSA) enforcement make one conclusion unavoidable: The DSCSA is both a regulatory mandate and a criminal risk boundary.

Investigations Blog
Brothers Convicted in $100 Million HIV Drug Fraud Scheme
November 3, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
Deal Dynamics in Life Sciences: Compliance, Pricing, and Smart M&As
October 29, 2025
Stephanie Trunk

Join AFS Life Sciences Partner Stephanie Trunk and Darshan Kulkarni, Life Sciences regulatory and compliance attorney, to unpack the recent acceleration of mergers and acquisitions across the life sciences sector.

Investigations Blog
Private Equity Firm Not Liable for Alleged FCA Retaliation Claims by Former Employee of Portfolio Company
October 27, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Seizes $15 Billion in Bitcoin in Cryptocurrency Fraud Scheme
October 20, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth Satarov, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

News
Grimm Quoted on Immigration Enforcement Impact on Hospitals and Health Care
October 14, 2025
Douglas A. Grimm

Health Care Practice Leader Douglas Grimm was quoted on the increasingly complex legal protocols hospitals must navigate following the rollback of a Biden-era policy restricting immigration enforcement in hospitals.

Investigations Blog
Fourth Circuit Appeal Challenges Six-Year Sentence in $10 Million Medicaid Fraud Case
October 13, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Mattie Bowden, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
Court Upholds Pension Reductions Under MPRA, No Taking Found
October 10, 2025
Alison Lima Andersen, Margherita A. Capolino

On August 18, the US Court of Appeals for the Federal Circuit issued a significant decision in King v. United States, affirming that reductions in multiemployer pension benefits authorized by the Multiemployer Pension Reform Act of 2014 (MPRA) are not takings under the Fifth Amendment.

News
Grimm Quoted on Hospital Challenges During Government Shutdown
October 7, 2025
Douglas A. Grimm

Health Care Practice Leader Douglas Grimm was quoted on the impact of the ongoing government shutdown on hospitals and healthcare providers.

News
Aging Populations, Tight Margins: Why Health Systems Need Post-Acute Strategy Now
October 6, 2025
Anne M. Murphy

The time has never been better for the acute and post-acute healthcare sectors to develop strategic relationships.

Investigations Blog
$37 Million FCA Settlement: Semler Scientific and Bard Resolve Medicare False Claims Over FloChec/QuantaFlo
October 6, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Mattie Bowden, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Events
Webinar: Overpayment Recoveries by Health Insurers
October 1, 2025
David S. Greenberg

Health Care Partner David Greenberg will present in a BARBRI CLE course titled “Overpayment Recoveries by Health Insurers: Bringing and Defending Claims, Evaluating Merits, Scope of Recovery” on October 1, 2025.

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

Back to Top